La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
62 hedge funds and large institutions have $279M invested in La Jolla Pharmaceutical Company in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 13 closing their positions.
116% more call options, than puts
Call options by funds: $4.59M | Put options by funds: $2.13M
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
13% less funds holding
Funds holding: 71 → 62 (-9)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
27% less capital invested
Capital invested by funds: $383M → $279M (-$104M)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.73M |
| 2 |
BC
Broadfin Capital
New York
|
+$1.21M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.12M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$971K |
| 5 |
Millennium Management
New York
|
+$744K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Asset Management One
Tokyo,
Japan
|
-$3.07M |
| 2 |
RI
RTW Investments
New York
|
-$1.61M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.59M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$1.49M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$856K |
LJPC Hedge Fund Activity: Q4 2016 in Review
62 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q4 2016, worth a combined $279M — down 27% from $383M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of LJPC and 5 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 25 added.
The largest buyer was Sabby Management, adding an estimated $1.73M. The largest seller was Asset Management One, exiting entirely with an estimated $3.07M sold.
- 62 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q4 2016, down from 71 in Q3 2016.
- Funds reported $279M of La Jolla Pharmaceutical Company stock for Q4 2016, down 27% quarter-over-quarter.
- 5 funds opened new La Jolla Pharmaceutical Company positions in Q4 2016 and 13 closed out, a net change of -8 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q4 2016 was Sabby Management, an estimated $1.73M added.
- The largest La Jolla Pharmaceutical Company seller in Q4 2016 was Asset Management One, an estimated $3.07M sold.
Based on aggregated 13F filings for Q4 2016.